黑料网

The innovative research seeks to identify putative causal knee OA risk variants, map them to their target genes, and quantify their phenotypic impact in chondrocytes.

The research showed early deletion of Ccr2 in aggrecan-expressing cells reduces the initiation, but not the progression, of post traumatic osteoarthritis and its associated pain.

Read about TARC's Strategic Planning Retreat, get an update from our Director, and learn about TARC grants, our upcoming Research Day and seminars, the key offerings of our CCCR, as well as spotlights/kudos for our team members.

Members of the Thurston Arthritis Research Center (TARC) and their families recently braved the heat to "walk the walk" at the 2020 AF event, held in Raleigh, N.C.

This award includes support for him to attend the 2022 ACR Convergence Meeting in Philadelphia, where he will present his abstract, 鈥淩edoxosomes Mediate a Feed-forward Loop of Cartilage Matrix Destruction Through 伪5尾1 Integrin Signaling in Response to a Fibronectin Matrikine鈥�.

The 5-year, K24 award from NIH/NIAMS will leverage Dr. Nelson's ongoing POR program, enhance her professional development and that of her trainees, and support her mentoring early stage investigators.

The aim of this 1-year award is to advance equity in lupus clinical trials by identifying, synthesizing, and disseminating innovative approaches and best practices to advance participant diversity in lupus clinical trials.

This research helps address an urgent need to understand the factors that promote progression and worsening of multi-joint osteoarthritis (MJOA), a common but understudied, progressive disease.

Dr. Sheikh was the 黑料网 Principal Investigator for this study, which was conducted at 黑料网's Clinical & Translational Research Center (CTRC), a resource through NC TraCS.

If access to this medicine were to be become limited as the result of recent legal rulings, it would be a detriment to rheumatology patients who need it, according to Dr. Jonas.